ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Paris, Île-de-France

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Nasal Polyps
Rhinosinusitis
Allergic Rhinitis
Rhinitis
Sinusitis
Respiration Disorders

Asthma trials near Paris, Île-de-France, FRA:

Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma. (ARRIVAL)

administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma..Study det...

Enrolling
Severe Asthma
Combination Product: Budesonide/formoterol
Combination Product: Mannitol

Phase 3

AstraZeneca
AstraZeneca

Créteil, France and 83 other locations

in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...

Enrolling
Asthma
Drug: Placebo
Drug: Benralizumab

Phase 3

AstraZeneca
AstraZeneca

Paris, France and 83 other locations

To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...

Enrolling
Asthma
Biological: Tezepelumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Paris, France and 115 other locations

The main objective of this study is to evaluate efficacy and safety of patient's learning in self-taking of prescribed asthma maintenance tr...

Active, not recruiting
Asthma in Children
Device: JOE
Ludocare

Paris, France and 12 other locations

BID using a dry-powder inhaler at one dose level over a 12-week Treatment period in adult participants with uncontrolled moderate-to-severe asthma...

Enrolling
Asthma
Drug: AZD4604
Other: Placebo

Phase 2

AstraZeneca
AstraZeneca

Antony, France and 158 other locations

treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...

Enrolling
Asthma
Wheezing
Drug: Placebo
Drug: Dupilumab

Phase 3

Sanofi
Sanofi

Paris, France and 57 other locations

of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...

Active, not recruiting
Asthma
Biological: GSK3511294 (Depemokimab)
Biological: Mepolizumab

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Paris, France and 419 other locations

administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, receiving medium -to -high dose inhaled c...

Enrolling
Asthma
Device: Inhaler
Drug: AZD8630

Phase 2

AstraZeneca
AstraZeneca

Paris, France and 218 other locations

treatments in patients undergoing pulmonary care for asthma and/or COPD, who are receiving treatment with Innovair® or Trimbow®. These two ...

Enrolling
Asthma COPD
Device: Hephaï
Hephai

Paris, France and 4 other locations

Asthma is a common pathology, with a prevalence of 6 to 8% and more than 4 million patients in France. Its management is based on different ...

Active, not recruiting
Asthma
Drug: Pre-filled syringe, mepolizumab 100 mg/month
Drug: Auto-injector pen, mepolizumab 100 mg/month

Phase 4

Civil Hospices of Lyon
Civil Hospices of Lyon

Paris, France and 7 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems